Literature DB >> 15052620

Motor function-muscle strength relationship in spinal muscular atrophy.

Luciano Merlini1, Enrico Bertini, Carlo Minetti, Tiziana Mongini, Lucia Morandi, Corrado Angelini, Giuseppe Vita.   

Abstract

The relationship between motor function and muscle strength in patients with spinal muscular atrophy (SMA) is still controversial. In 120 genetically proven SMA patients, aged 5 years or older, we measured muscle strength in the arms and legs by a hand-held dynamometer, forced vital capacity by a spirometer, and the time needed to walk 10 m, arise from the floor, and climb steps. SMA patients had markedly reduced muscle strength, approximating 20% of that predicted from age- and gender-matched normative data. Knee extensors were the weakest muscles in SMA patients. The young ambulant SMA patients performed better than adults in all the timed tests and had greater muscle strength on knee extension. This study shows a good relationship between motor ability and muscle strength in SMA and confirms that age-related loss of function in SMA is due to loss of muscle strength.

Entities:  

Mesh:

Year:  2004        PMID: 15052620     DOI: 10.1002/mus.20018

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

1.  A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Thomas O Crawford; Charles Scott; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2006-06-05       Impact factor: 4.296

2.  Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.

Authors:  J Montes; M P McDermott; W B Martens; S Dunaway; A M Glanzman; S Riley; J Quigley; M J Montgomery; D Sproule; R Tawil; W K Chung; B T Darras; D C De Vivo; P Kaufmann; R S Finkel
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

3.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

Review 4.  The Genetics of Spinal Muscular Atrophy: Progress and Challenges.

Authors:  Michelle A Farrar; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Prospective cohort study of spinal muscular atrophy types 2 and 3.

Authors:  Petra Kaufmann; Michael P McDermott; Basil T Darras; Richard S Finkel; Douglas M Sproule; Peter B Kang; Maryam Oskoui; Andrei Constantinescu; Clifton L Gooch; A Reghan Foley; Michele L Yang; Rabi Tawil; Wendy K Chung; William B Martens; Jacqueline Montes; Vanessa Battista; Jessica O'Hagen; Sally Dunaway; Jean Flickinger; Janet Quigley; Susan Riley; Allan M Glanzman; Maryjane Benton; Patricia A Ryan; Mark Punyanitya; Megan J Montgomery; Jonathan Marra; Benjamin Koo; Darryl C De Vivo
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

Review 6.  Spinal muscular atrophy.

Authors:  Maryam Oskoui; Petra Kaufmann
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 7.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

8.  Natural history of 10-meter walk/run test performance in spinal muscular atrophy: A longitudinal analysis.

Authors:  Kristin J Krosschell; Elise L Townsend; Michael Kiefer; Sarah D Simeone; Katelyn Zumpf; Leah Welty; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2021-08-24       Impact factor: 4.296

9.  Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results.

Authors:  Luciano Merlini; Patrizia Sabatelli; Annarita Armaroli; Saverio Gnudi; Alessia Angelin; Paolo Grumati; Maria Elena Michelini; Andrea Franchella; Francesca Gualandi; Enrico Bertini; Nadir Mario Maraldi; Alessandra Ferlini; Paolo Bonaldo; Paolo Bernardi
Journal:  Oxid Med Cell Longev       Date:  2011-10-17       Impact factor: 6.543

10.  Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

Authors:  Maria Teresa Miscione; Francesca Bruno; Claudio Ripamonti; Giuliana Nervuti; Riccardo Orsini; Cesare Faldini; Massimo Pellegrini; Daniela Cocchi; Luciano Merlini
Journal:  ScientificWorldJournal       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.